Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $90.7964 (3.06%) ($88.4453 - $90.8656) on Tue. Oct. 16, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.5% (three month average) | RSI | 46 | Latest Price | $90.7964(3.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(50%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.75% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.75% (StdDev 1.5%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
1 - 5 Day Possible Target | $87.08(-4.09%) | Resistance Level | $91.25 | 5 Day Moving Average | $89.62(1.31%) | 10 Day Moving Average | $91.02(-0.25%) | 20 Day Moving Average | $91.25(-0.5%) | To recent high | -6% | To recent low | 4.5% | Market Cap | $160.191b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |